A 6-month depot formulation of leuprolide acetate is safe and effective in daily clinical practice: a non-interventional prospective study in 1273 patients
<p>Abstract</p> <p>Background</p> <p>Testosterone stimulates growth in many prostate tumours. The established GnRH analogue leuprolide acetate is incorporated in a novel biodegradable polymer matrix (Atrigel<sup>® </sup>delivery system), that can be administ...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-07-01
|
| Series: | BMC Urology |
| Online Access: | http://www.biomedcentral.com/1471-2490/11/15 |